Mr. Chairman, I have an amendment at the desk. Mr. Chairman, today, along with the support of my colleague, Representative Eshoo, I am offering this amendment to help an estimated 250,000 ailing veterans of the first gulf war, over one-…
Mr. Chairman, I have an amendment at the desk.
Mr. Chairman, today, along with the support of my colleague, Representative Eshoo, I am offering this amendment to help an estimated 250,000 ailing veterans of the first gulf war, over one- third of those who served. It will bring the modest budget for the Gulf War Illness Research program within the congressionally directed Medical Research program in line with that of its peer programs, to $10 million.
Too many veterans of the first gulf war suffer from persistent symptoms, such as chronic headache, widespread pain, cognitive difficulties, unexplained fatigue, gastrointestinal problems, respiratory symptoms, and other abnormalities that are not explained by traditional medical or psychiatric diagnoses. Research shows that, as these brave soldiers age, they are at double the risk for ALS, or Lou Gehrig's disease, as are their non-deployed peers. There may also be connections to multiple sclerosis and Parkinson's disease. Sadly, there are no known treatments for the lifelong pain these veterans endure.
In a new landmark report, the Institute of Medicine has recognized that and has called for a major national research effort to identify treatments. The scientific community has responded with a dramatic increase in the quality and quantity of proposals that are submitted to the Congressionally Directed Medical Research Programs, otherwise known as CDMRP.
In the FY12 Defense appropriations bill, CDMRP programs, with direct relevance to current forces, received a 25 percent increase. The research conducted by the Gulf War Veterans Illnesses Research program is vital not only for ill gulf war veterans but also for other U.S. military forces. As summarized by the IOM committee chair on the topic, Dr. Stephen Hauser, gulf war illnesses research is ``vital to the health and effectiveness of current and future military forces in addition to gulf war veterans.''
Most encouraging, CDMRP-funded researchers have completed the first successful pilot study of a medication to treat one of the major symptoms of gulf war illness. Just last month, a report was released on the first successful medication treatment study in the history of gulf war illness research. The study showed that the low-cost supplement, CoQ10, produced significant improvement in one of the most serious symptoms of gulf war illness, fatigue with exertion, as well as improvements in nearly every other symptom. It is not a cure, and the study needs to be replicated in a larger group; but the result is extremely encouraging. The next step is for clinical trials, which will only be funded by the CDMRP.
The amendment's offset comes from the Pentagon channel, which is costly--over $29 million in the past 3 fiscal years. It's redundant. There are eight other Armed Forces Network Television services which provide news, entertainment, lifestyle, documentary, and religious programming to servicemembers and their families across the globe, and it doesn't provide a vital service; but this research is critical to our troops in the field now as well as to those who will be fighting in the future.
According to the VA's Research Advisory Committee on Gulf War Veterans' Illnesses, the known causes of gulf war illness are from exposures incurred in Iraq, like certain pesticides, or are from exposures incurred before deployment, like pyridostigmine bromide, which is a drug taken as an antidote to the nerve gas sarin. There is also some evidence of a link between gulf war illness and a low-level exposure to nerve agents, a close proximity to oil well fires, the receipt of multiple vaccines, and combinations of gulf war exposures.
Current forces in Iraq and Afghanistan can still incur each of these exposures. That is why the chair of the IOM committee's report on gulf war illnesses said: ``This IOM report makes findings and recommendations vital to the health and effectiveness of current and future U.S. military forces in addition to gulf war veterans.''
This is a time for us to say thank you to those who have served, to say that we understand the suffering that gulf war veterans have had with this illness and that we are dedicated to finding higher levels of research to make sure that we can relieve their suffering.
I yield back the balance of my time.
Mr. Chairman, I demand a recorded vote.